Loading
Latest filing published 15 Jun 2016 for InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,).
No signal scores available.
Terese Gieselman is a declared insider of InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,), with filings sourced from SEDI. Over a trading history stretching from 4 April 2014 to 9 June 2016, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 15 June 2016: a transaction, in InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,). This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations